// App-Quantinova.ai

597 2014 ATVB : Nobiletin Reduces Intestinal Lipoprotein Production in LDL Receptor-Null Mice With Diet-Induced Insulin Resistance

Researchers

Presenter

  • Brian G Sutherland

Principal Investigators

  • Dawn E Telford

  • Murray W Huff

Medical Centers

  • Robarts Reserach Institute, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Fatty Liver Disease

  • Dyslipidemia

  • Obesity

Biomarkers

  • Periplakin

  • Insulin

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • VLTS-934

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved